MeiraGTx Holdings (MGTX) Share-based Compensation (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Share-based Compensation of $5.6 million for Q4 2025, up 18.4% on a QoQ basis from $4.7 million in Q3 2025, and down 75.65% year-over-year from $22.9 million in Q4 2024.
MeiraGTx Holdings (MGTX) Share-based Compensation (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- Quarterly Share-based Compensation fell 75.65% year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.2 million (down 8.72% YoY) and the FY2025 annual result came in at $24.7 million, down 1.95% from the prior year.
- Share-based Compensation was $5.6 million for Q4 2025 at MeiraGTx Holdings, up from $4.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $22.9 million in Q4 2024 and bottomed at $2.1 million in Q1 2025.
- A 5-year average of $6.6 million and a median of $5.7 million in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation soared 42.83% — and 2025, when it plunged 75.65%.
- MeiraGTx Holdings' Share-based Compensation stood at $7.1 million in 2021, then fell by 4.61% to $6.8 million in 2022, then declined by 0.59% to $6.8 million in 2023, then soared by 237.78% to $22.9 million in 2024, then plunged by 75.65% to $5.6 million in 2025.
- Business Quant data shows MGTX's Share-based Compensation at $5.6 million in Q4 2025, $4.7 million in Q3 2025, and $5.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 5.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.57 Mn |
| Dec 31, 2025 | 5.57 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 22.85 Mn |
| Dec 31, 2024 | 22.85 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Sep 30, 2023 | 6.77 Mn |
| Jun 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | 7.27 Mn |